Atlas Trials

Long-Term Outcomes of Teplizumab in Routine Clinical Care

Clinical trial NCT07360080 · RECRUITING

Trial details

NCT number
NCT07360080
Sponsor
Sanofi
Status
RECRUITING
Study type
OBSERVATIONAL
Type 1 Diabetes
Start date
2026-03-19
Primary completion
2035-10-29
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.